Test for Bladder Cancer (URODIAG®): Non-Invasive Monitoring
For patients under bladder cancer monitoring. URODIAG® is an innovative non-invasive test for bladder cancer surveillance that is analyzed with a urine sample: easy, fast, no prior preparation needed, and with high accuracy (99%).
¿Where is it done?
To purchase this test, fill out the form and we will send you a quote.
If you prefer, you can go directly to a Laboratorio Echevarne center where they will provide you with the necessary information to carry out the test.
URODIAG® is intended for patients already diagnosed with non-muscle-invasive bladder cancer and offers a less invasive alternative to traditional monitoring through periodic cystoscopies. From a simple urine sample, the laboratory extracts DNA and performs a real-time quantitative PCR to detect:
Mutations in the FGFR3 gene and Methylation levels in the HS3ST2, SEPTIN9, and SLIT2 genes. These genetic markers are directly associated with the presence and possible recurrence of non-muscle-invasive bladder cancer.
-A positive result indicates genetic alterations compatible with active disease.
-A negative result rules out the presence of aggressive bladder tumors with more than 99% accuracy, which may allow spacing out or avoiding unnecessary cystoscopies.
The laboratory issues a detailed report that includes the detected alterations and their clinical interpretation, helping the physician personalize treatment and adjust the surveillance plan.
Sample type: Urine
Results in 15 days
¿Is it suitable for me?
This test is exclusively intended for:
• Patients already diagnosed with non-muscle invasive bladder cancer (NMIBC) of low, intermediate, or high risk, who are in the follow-up phase to detect possible recurrences.
Test for Bladder Cancer (URODIAG®): Non-Invasive Monitoring
Free
Resolvemos todas tus dudas
Benefits
• It is a non-invasive, comfortable, and painless procedure.
• It does not require hospitalization or anesthesia.
• Reduces the frequency of follow-up cystoscopies.
• Offers high accuracy (99%) to rule out aggressive tumors.
• Helps personalize your medical surveillance plan.
Results
Your results, clear and on time:
Within a maximum of 15 business days, we will send you a notification by email or SMS.
With that notification, you will be able to access and download your results from our online Patient Portal.
Once you have your report, visit a healthcare professional so they can interpret it with you and, if necessary, create a personalized action plan.
Frequently Asked Questions
Can you tell me if I am at risk of bladder cancer?
Indicates the recurrence of bladder cancer.
What display is used?
First morning urine sample.
Why should I take this test if I already get Pap smears?
The genetic test allows for the detection of cancer recurrence at earlier stages, improving sensitivity.
How often should it be repeated?
Depending on age and medical recommendations, it is usually alternated with cytology in screening programs. At the same intervals as part of surveillance follow-up.
NUTRITION
·
WELLNESS
·
ONCOLOGY AND GENETICS
·
PREVENTION
·
SEXUAL HEALTH
·
FERTILITY AND PREGNANCY
·
SPORT
·
HOME
Related Products
Customer Reviews
“
I only had to provide a urine sample, with no prior preparation, and the results were very accurate. It allowed me to space out the cystoscopies and continue being monitored with complete confidence.
”
Adrià Q.
Peñaranda de Bracamonte, Salamanca
“
Thanks to the test, I can now track my progress more comfortably and without pain. The results are clear and fast, and they give me a lot of confidence. It's a huge step forward for patients like me.